Cultivation Medicinal plants demand intensive management. Different species each require their own distinct conditions of cultivation. The
World Health Organization recommends the use of
rotation to minimise problems with pests and plant diseases. Cultivation may be traditional or may make use of
conservation agriculture practices to maintain organic matter in the soil and to conserve water, for example with
no-till farming systems. In many medicinal and aromatic plants, plant characteristics vary widely with soil type and cropping strategy, so care is required to obtain satisfactory yields.
Preparation Medicinal plants are often tough and fibrous, requiring some form of preparation to make them convenient to administer. According to the Institute for Traditional Medicine, common methods for the preparation of herbal medicines include
decoction, powdering, and extraction with alcohol, in each case yielding a mixture of substances. Decoction involves crushing and then boiling the plant material in water to produce a liquid extract that can be taken orally or applied topically. Powdering involves drying the plant material and then crushing it to yield a powder that can be compressed into
tablets. Alcohol extraction involves soaking the plant material in cold wine or distilled spirit to form a
tincture. Traditional
poultices were made by boiling medicinal plants, wrapping them in a cloth, and applying the resulting parcel externally to the affected part of the body. When modern medicine has identified a drug in a medicinal plant, commercial quantities of the drug may either be
synthesised or extracted from plant material, yielding a pure chemical. Extraction can be practical when the compound in question is complex.
Usage 's shop in the
souk of
Marrakesh, Morocco Plant medicines are in wide use around the world. In most of the developing world, especially in rural areas, local
traditional medicine, including herbalism, is the only source of health care for people, while in the
developed world,
alternative medicine including use of
dietary supplements is marketed aggressively using the claims of traditional medicine. As of 2015, most products made from medicinal plants had not been tested for their safety and efficacy, and products that were marketed in developed economies and provided in the undeveloped world by traditional healers were of uneven quality, sometimes containing dangerous contaminants.
Traditional Chinese medicine makes use of a wide variety of plants, among other materials and techniques. Researchers from
Kew Gardens found 104 species used for
diabetes in Central America, of which seven had been identified in at least three separate studies. The
Yanomami of the Brazilian Amazon, assisted by researchers, have described 101 plant species used for traditional medicines. Drugs derived from plants including opiates, cocaine and cannabis have both medical and
recreational uses. Different countries have at various times made
use of illegal drugs, partly on the basis of the risks involved in taking
psychoactive drugs.
Effectiveness tree contains the
alkaloid quinine, traditionally given for
malaria. Plant medicines have often not been tested systematically, but have come into use informally over the centuries. By 2007, clinical trials had demonstrated potentially useful activity in nearly 16% of herbal extracts; there was limited in vitro or in vivo evidence for roughly half the extracts; there was only phytochemical evidence for around 20%; 0.5% were allergenic or toxic; and some 12% had basically never been studied scientifically. Cancer Research UK caution that there is no reliable evidence for the effectiveness of herbal remedies for cancer. A 2012
phylogenetic study built a family tree down to
genus level using 20,000 species to compare the medicinal plants of three regions, Nepal, New Zealand and the Cape of South Africa. It discovered that the species used traditionally to treat the same types of condition belonged to the same groups of plants in all three regions, giving a "strong phylogenetic signal".
Regulation , is regulated by a government department,
AYUSH. The World Health Organization (WHO) has been coordinating a network called the International Regulatory Cooperation for Herbal Medicines to try to improve the quality of medical products made from medicinal plants and the claims made for them. In 2015, only around 20% of countries had well-functioning regulatory agencies, while 30% had none, and around half had limited regulatory capacity. WHO has set out a strategy for traditional medicines with four objectives: to integrate them as policy into national healthcare systems; to provide knowledge and guidance on their safety, efficacy, and quality; to increase their availability and affordability; and to promote their rational, therapeutically sound usage. Therapeutically important drugs like
camptothecin (from
Camptotheca acuminata, used in traditional Chinese medicine) and
taxol (from the Pacific yew,
Taxus brevifolia) were derived from medicinal plants. Hundreds of compounds have been identified using
ethnobotany, investigating plants used by indigenous peoples for possible medical applications. Some important phytochemicals, including curcumin,
epigallocatechin gallate,
genistein and
resveratrol are
pan-assay interference compounds, meaning that
in vitro studies of their activity often provide unreliable data. As a result, phytochemicals have frequently proven unsuitable as the lead substances in
drug discovery. In the United States over the period 1999 to 2012, despite several hundred applications for
new drug status, only two
botanical drug candidates had sufficient evidence of medicinal value to be approved by the
Food and Drug Administration. Among cancer treatments, of 185 small-molecule drugs approved in the period from 1981 to 2019, 65% were derived from or inspired by natural substances. Plant medicines can cause adverse effects and even death, whether by side-effects of their active substances, by adulteration or contamination, by overdose, or by inappropriate prescription. Many such effects are known, while others remain to be explored scientifically. There is no reason to presume that because a product comes from nature it must be safe: the existence of powerful natural poisons like atropine and nicotine shows this to be untrue. Further, the high standards applied to conventional medicines do not always apply to plant medicines, and dose can vary widely depending on the growth conditions of plants: older plants may be much more toxic than young ones, for instance. Plant extracts may interact with conventional drugs, both because they may provide an increased dose of similar compounds, and because some phytochemicals interfere with the body's systems that metabolise drugs in the liver including the
cytochrome P450 system, making the drugs last longer in the body and have a cumulative effect. Plant medicines can be dangerous during pregnancy. Since plants may contain many different substances, plant extracts may have complex effects on the human body.
Quality, advertising, and labelling Herbal medicine and dietary supplement products have been criticized as not having sufficient standards or scientific evidence to confirm their contents, safety, and presumed efficacy. Companies often make false claims about their herbal products promising health benefits that aren't backed by evidence to generate more sales. The market for dietary supplements and nutraceuticals grew by 5% during the COVID-19 pandemic, which led to the United States taking action to stop the deceptive marketing of herbal products to combat the virus. ==Threats==